Home

Download

Statistics

Examples

Help

Contact

Gene: ENSG00000149639

Summary for SOGA1

Gene summary

Gene information	Ensembl ID	ENSG00000149639
	Gene symbol	SOGA1
	Gene name	suppressor of glucose, autophagy associated 1
	HGNC	16111
	Entrez ID	140710
	Gene type	protein_coding
	Synonyms	SOGA1\|dJ132F21.1\|FLJ44670\|SOGA
	UniProtAcc	O94964

Drugs associated with this gene(DrugBank).

Gene ID

Gene Symbol

Drug ID

Drug Name

Drug Type

Cancer therapeutic drugs associated with this gene(NCI).

Gene ID

Gene Name

Drug ID

Drug Name

Drug Type

Cancer

Top

Structure and expression level for SOGA1

AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.
∗For more information on exon skipping events please check the ExonskipDB database.
∗For more information on exon skipping events please check the CAeditome database.

Landscape of gene expressions across multiple cancer types.

Differentially expressed gene analysis between tumor male and tumor female samples.

Coding Name

Base Mean

log2FoldChange

lfcSE

Stat

P value

P.adjust Value

Cancer Type

Differentially expressed gene analysis between tumor male and normal male samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
SOGA1	2.85e+03	-1.09e+00	2.32e-01	-4.70e+00	2.61e-06	1.83e-05	BLCA
SOGA1	2.46e+03	-1.12e+00	3.30e-01	-3.40e+00	6.66e-04	1.80e-03	KICH
SOGA1	1.42e+03	2.15e+00	2.28e-01	9.41e+00	4.77e-21	5.90e-19	CHOL

Differentially expressed gene analysis between tumor female and normal female samples.

Coding Name

Base Mean

log2FoldChange

lfcSE

Stat

P value

P.adjust Value

Cancer Type

Top

Sex-biased somatic mutation for SOGA1

∗For more information on exon skipping events please check the ExonskipDB database.

Gene ID

Cancer Type

Hugo Symbol

Male

Female

pval

ci.up

ci.low

adjPval

Top

DNA methylation with beta values for SOGA1

Landscape of DNA methylation across multiple cancer types.

Differentially expressed CpG sites between male tumor and female tumor patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
BRCA	cg06477069	chr20:36864975	CGI:chr20:36862598-36864402	promoter	3.57e-01	2.50e-01	2.63e+00	8.58e-03	2.52e-02	1.07e-01
ACC	cg16144843	chr20:36864318	CGI:chr20:36862598-36864402	promoter	2.10e-01	3.17e-01	-2.29e+00	2.21e-02	3.69e-02	-1.08e-01

Differentially expressed CpG sites between male tumor and male normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
LUSC	cg01844321	chr20:36862412	CGI:chr20:36862598-36864402	promoter,gene body	3.11e-01	4.16e-01	-2.92e+00	3.55e-03	6.33e-03	-1.05e-01
KIRP	cg06477069	chr20:36864975	CGI:chr20:36862598-36864402	promoter	4.42e-01	6.09e-01	-3.19e+00	1.43e-03	2.47e-03	-1.67e-01
CHOL	cg01844321	chr20:36862412	CGI:chr20:36862598-36864402	promoter,gene body	2.71e-01	4.12e-01	-1.99e+00	4.65e-02	4.65e-02	-1.41e-01

Differentially expressed CpG sites between female tumor and female normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
HNSC	cg01844321	chr20:36862412	CGI:chr20:36862598-36864402	promoter,gene body	3.36e-01	2.22e-01	2.41e+00	1.60e-02	2.42e-02	1.14e-01
HNSC	cg06477069	chr20:36864975	CGI:chr20:36862598-36864402	promoter	4.39e-01	3.20e-01	2.31e+00	2.10e-02	2.84e-02	1.18e-01

Top

Exon skipping events with PSI in TCGA for SOGA1

∗Please access ExonSkipDB for exon skipping annotation.

Landscape of exon skipping events across multiple cancer types.

Differentially expressed exon skipping events between male tumor and female tumor patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between male tumor and male normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between female tumor and female normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Top

RNA A-to-I editing events in TCGA for SOGA1

∗Please access CAeditome for RNA editing annotation.

Landscape of RNA editing events across multiple cancer types.

Differentially expressed RNA editing events between male tumor and female tumor patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
BRCA	SOGA1-003	chr20_36781414_-	6.34e-01	5.13e-01	2.33e+00	2.00e-02	4.97e-02	1.21e-01
LUAD	SOGA1-003	chr20_36781484_-	2.30e-01	2.67e-01	-2.58e+00	9.80e-03	2.85e-02	-3.65e-02
LGG	SOGA1-003	chr20_36782014_-	1.73e-01	1.38e-01	2.15e+00	3.17e-02	4.76e-02	3.58e-02
THCA	SOGA1-003	chr20_36781454_-	2.14e-01	1.78e-01	1.97e+00	4.86e-02	4.95e-02	3.60e-02
HNSC	SOGA1-003	chr20_36781454_-	1.80e-01	2.19e-01	-2.55e+00	1.07e-02	3.64e-02	-3.90e-02
HNSC	SOGA1-003	chr20_36781534_-	1.74e-01	2.14e-01	-2.20e+00	2.77e-02	4.41e-02	-4.03e-02
LUSC	SOGA1-003	chr20_36781953_-	1.42e-01	1.99e-01	-2.33e+00	1.96e-02	4.91e-02	-5.70e-02
LUSC	SOGA1-003	chr20_36782780_-	1.43e-01	1.81e-01	-2.41e+00	1.59e-02	4.91e-02	-3.82e-02
SKCM	SOGA1-003	chr20_36781288_-	2.07e-01	2.47e-01	-1.97e+00	4.85e-02	4.93e-02	-4.04e-02
SKCM	SOGA1-003	chr20_36781291_-	1.80e-01	2.16e-01	-2.14e+00	3.22e-02	4.90e-02	-3.60e-02
SKCM	SOGA1-003	chr20_36781484_-	1.96e-01	2.16e-01	-2.21e+00	2.70e-02	4.90e-02	-1.98e-02
SKCM	SOGA1-003	chr20_36783501_-	1.83e-01	2.25e-01	-2.47e+00	1.34e-02	4.90e-02	-4.14e-02
BLCA	SOGA1-003	chr20_36781370_-	7.20e-01	8.29e-01	-2.26e+00	2.40e-02	4.98e-02	-1.09e-01
BLCA	SOGA1-003	chr20_36783501_-	2.59e-01	2.17e-01	2.08e+00	3.78e-02	4.98e-02	4.21e-02
STAD	SOGA1-003	chr20_36781949_-	1.81e-01	2.30e-01	-2.48e+00	1.32e-02	4.96e-02	-4.85e-02
KIRP	SOGA1-003	chr20_36782112_-	4.22e-01	3.50e-01	2.08e+00	3.74e-02	4.80e-02	7.19e-02
SARC	SOGA1-003	chr20_36781414_-	6.81e-01	6.07e-01	2.70e+00	6.97e-03	4.85e-02	7.48e-02
SARC	SOGA1-003	chr20_36782031_-	2.17e-01	1.80e-01	1.96e+00	4.96e-02	4.97e-02	3.73e-02
SARC	SOGA1-003	chr20_36782105_-	1.32e-01	2.01e-01	-2.14e+00	3.25e-02	4.95e-02	-6.88e-02
PCPG	SOGA1-003	chr20_36781450_-	2.57e-01	3.39e-01	-2.35e+00	1.86e-02	4.98e-02	-8.14e-02
READ	SOGA1-003	chr20_36781373_-	7.67e-01	5.15e-01	2.54e+00	1.12e-02	4.67e-02	2.52e-01
GBM	SOGA1-003	chr20_36781306_-	2.19e-01	2.62e-01	-2.05e+00	4.04e-02	4.96e-02	-4.28e-02
GBM	SOGA1-003	chr20_36783501_-	1.45e-01	2.30e-01	-2.13e+00	3.32e-02	4.96e-02	-8.47e-02
ESCA	SOGA1-003	chr20_36781370_-	7.40e-01	6.77e-01	2.36e+00	1.84e-02	4.99e-02	6.36e-02
ESCA	SOGA1-003	chr20_36781373_-	6.71e-01	5.85e-01	2.23e+00	2.57e-02	4.99e-02	8.65e-02
THYM	SOGA1-003	chr20_36781288_-	1.94e-01	3.00e-01	-2.00e+00	4.60e-02	4.88e-02	-1.06e-01
THYM	SOGA1-003	chr20_36783501_-	1.52e-01	2.62e-01	-2.01e+00	4.46e-02	4.87e-02	-1.11e-01

Differentially expressed RNA editing events between male tumor and male normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
KIRC	SOGA1-003	chr20_36781288_-	2.39e-01	1.77e-01	2.88e+00	4.04e-03	9.81e-03	6.18e-02
KIRC	SOGA1-003	chr20_36781373_-	6.37e-01	7.28e-01	-2.77e+00	5.52e-03	1.22e-02	-9.10e-02
KIRC	SOGA1-003	chr20_36781414_-	4.68e-01	5.30e-01	-2.51e+00	1.22e-02	2.04e-02	-6.22e-02
KIRC	SOGA1-003	chr20_36783501_-	2.15e-01	1.60e-01	2.52e+00	1.16e-02	1.97e-02	5.48e-02
THCA	SOGA1-003	chr20_36781682_-	2.12e-01	1.35e-01	2.75e+00	5.96e-03	1.37e-02	7.75e-02
HNSC	SOGA1-003	chr20_36781373_-	6.97e-01	5.96e-01	2.06e+00	3.94e-02	4.13e-02	1.01e-01
HNSC	SOGA1-003	chr20_36781423_-	2.93e-01	1.88e-01	2.54e+00	1.10e-02	1.52e-02	1.05e-01
HNSC	SOGA1-003	chr20_36782112_-	4.74e-01	3.26e-01	3.47e+00	5.21e-04	1.31e-03	1.48e-01
LUSC	SOGA1-003	chr20_36781288_-	2.23e-01	3.41e-01	-3.20e+00	1.38e-03	5.91e-03	-1.18e-01
LUSC	SOGA1-003	chr20_36781370_-	8.05e-01	6.73e-01	2.34e+00	1.94e-02	2.87e-02	1.32e-01
LUSC	SOGA1-003	chr20_36781414_-	5.32e-01	4.12e-01	2.50e+00	1.26e-02	2.24e-02	1.20e-01
LUSC	SOGA1-003	chr20_36781484_-	1.89e-01	2.62e-01	-4.14e+00	3.44e-05	5.16e-04	-7.22e-02
LUSC	SOGA1-003	chr20_36781966_-	3.04e-01	2.05e-01	2.54e+00	1.09e-02	2.04e-02	9.91e-02
LUSC	SOGA1-003	chr20_36782031_-	1.55e-01	2.41e-01	-2.65e+00	8.15e-03	1.72e-02	-8.58e-02
LUSC	SOGA1-003	chr20_36782097_-	2.09e-01	2.72e-01	-2.57e+00	1.01e-02	1.95e-02	-6.29e-02
LUSC	SOGA1-003	chr20_36782112_-	4.83e-01	4.11e-01	1.98e+00	4.74e-02	4.82e-02	7.15e-02
COAD	SOGA1-003	chr20_36781484_-	2.28e-01	3.07e-01	-2.04e+00	4.09e-02	4.33e-02	-7.96e-02
BLCA	SOGA1-003	chr20_36781484_-	2.27e-01	3.92e-01	-2.97e+00	3.00e-03	1.52e-02	-1.65e-01
BLCA	SOGA1-003	chr20_36782112_-	4.63e-01	2.73e-01	2.83e+00	4.63e-03	1.83e-02	1.90e-01
STAD	SOGA1-003	chr20_36781484_-	2.79e-01	4.10e-01	-2.10e+00	3.54e-02	4.29e-02	-1.31e-01
STAD	SOGA1-003	chr20_36782112_-	5.94e-01	4.18e-01	2.73e+00	6.35e-03	1.90e-02	1.76e-01
KIRP	SOGA1-003	chr20_36781373_-	6.73e-01	7.68e-01	-1.97e+00	4.87e-02	4.95e-02	-9.52e-02

Differentially expressed RNA editing events between female tumor and female normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
BRCA	SOGA1-003	chr20_36781288_-	2.38e-01	1.73e-01	4.33e+00	1.47e-05	4.42e-05	6.45e-02
BRCA	SOGA1-003	chr20_36781306_-	2.38e-01	1.95e-01	2.49e+00	1.29e-02	1.72e-02	4.35e-02
BRCA	SOGA1-003	chr20_36781370_-	7.94e-01	7.39e-01	4.16e+00	3.15e-05	8.78e-05	5.55e-02
BRCA	SOGA1-003	chr20_36781373_-	7.03e-01	6.43e-01	4.03e+00	5.59e-05	1.48e-04	6.04e-02
BRCA	SOGA1-003	chr20_36781414_-	5.13e-01	4.26e-01	5.15e+00	2.60e-07	1.08e-06	8.72e-02
BRCA	SOGA1-003	chr20_36781423_-	3.15e-01	2.67e-01	3.22e+00	1.28e-03	2.41e-03	4.76e-02
BRCA	SOGA1-003	chr20_36781450_-	2.82e-01	2.23e-01	4.66e+00	3.12e-06	1.07e-05	5.88e-02
BRCA	SOGA1-003	chr20_36781453_-	2.57e-01	1.84e-01	5.13e+00	2.87e-07	1.18e-06	7.34e-02
BRCA	SOGA1-003	chr20_36781454_-	2.02e-01	1.57e-01	2.58e+00	9.92e-03	1.39e-02	4.46e-02
BRCA	SOGA1-003	chr20_36781534_-	2.04e-01	1.73e-01	2.38e+00	1.73e-02	2.19e-02	3.07e-02
BRCA	SOGA1-003	chr20_36781682_-	2.34e-01	1.60e-01	5.84e+00	5.07e-09	2.82e-08	7.40e-02
BRCA	SOGA1-003	chr20_36781966_-	3.41e-01	3.05e-01	2.45e+00	1.43e-02	1.87e-02	3.69e-02
BRCA	SOGA1-003	chr20_36782013_-	1.68e-01	2.57e-01	-2.19e+00	2.85e-02	3.23e-02	-8.87e-02
BRCA	SOGA1-003	chr20_36782097_-	2.26e-01	1.53e-01	2.86e+00	4.24e-03	6.79e-03	7.29e-02
BRCA	SOGA1-003	chr20_36782112_-	5.65e-01	4.01e-01	9.30e+00	1.36e-20	3.60e-19	1.64e-01
BRCA	SOGA1-003	chr20_36783501_-	2.48e-01	1.81e-01	1.96e+00	4.99e-02	4.99e-02	6.63e-02
KIRC	SOGA1-003	chr20_36781484_-	2.47e-01	1.89e-01	2.92e+00	3.54e-03	1.53e-02	5.72e-02
THCA	SOGA1-003	chr20_36781288_-	2.01e-01	1.44e-01	2.41e+00	1.61e-02	2.32e-02	5.70e-02
THCA	SOGA1-003	chr20_36781370_-	7.59e-01	7.20e-01	1.98e+00	4.71e-02	4.81e-02	3.83e-02
THCA	SOGA1-003	chr20_36781373_-	6.99e-01	6.51e-01	2.33e+00	1.99e-02	2.69e-02	4.81e-02
THCA	SOGA1-003	chr20_36781534_-	2.11e-01	1.40e-01	3.95e+00	7.66e-05	5.25e-04	7.12e-02
THCA	SOGA1-003	chr20_36781966_-	2.70e-01	2.22e-01	2.32e+00	2.02e-02	2.72e-02	4.87e-02
HNSC	SOGA1-003	chr20_36781453_-	2.39e-01	1.65e-01	2.25e+00	2.41e-02	3.03e-02	7.38e-02
KICH	SOGA1-003	chr20_36781484_-	1.57e-01	2.60e-01	-2.76e+00	5.77e-03	1.25e-02	-1.03e-01

Protein coding RNA editing(s).

Editing Position

Variant Type

Gene Symbol

Transcript ID

NTchange

AAchange

Top

Sex-biased TF-Gene network for SOGA1

TFs related to SOGA1.
∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type	TF	Target Gene	Male Edge Score	Male Edge Threshold	Female Edge Score	Female Edge Threshold	Type
BRCA	ZNF235	SOGA1	4.30e+00	9.90e-01	1.89e+00	2.52e-04	Male-biased
BRCA	ZNF287	SOGA1	4.21e+00	9.88e-01	1.99e+00	4.83e-04	Male-biased
LAML	PLAGL2	SOGA1	2.81e+00	1.06e-03	4.27e+00	9.87e-01	Female-biased

SOGA1 related gene.
∗Only the gene encode TF might with this result.
∗For more information please check Sex-biased TF-Coding gene network.

Top

Sex-biased RBP-ES network for SOGA1

RBPs related to ES in SOGA1.
∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type

RBP

Target ES

Male Edge Score

Male Edge Threshold

Female Edge Score

Female Edge Threshold

Type

SOGA1 related ES.
∗Only the gene encode RBP might with this result.
∗For more information please check Sex-biased RBP-ES network in cancer.

Top

Sex-biased CeRNA regulation of gene

Sex-biased CeRNA regulation of gene.

Gene ID

ceRNA(lncRNA-miRNA-mRNA)

Group

Cancer Type

Top

Sex-biased eQTL regulation of gene

Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

eQTL

Description

Male-specific eQTL regulation.

SNP ID	SNP Info	Position to Gene	Effect Score	FDR	Cancer Type	Biased Type
rs2424918	chr20:32794964:C:T	-	-0.0990018770559025	0.039086370457437	HNSC	Female-baised eQTL
rs910085	chr20:32795547:T:G	-	-0.0990018770559025	0.039086370457437	HNSC	Female-baised eQTL
rs58203547	chr20:30376259:A:G	-	0.193458522873149	0.010608294552469	BLCA	Female-baised eQTL
rs6015420	chr20:38581919:G:T	-	0.135258149381829	0.0177722451270387	BLCA	Female-baised eQTL
rs11906476	chr20:36443138:A:G	-	-0.118773404894915	0.0242044034286254	BLCA	Female-baised eQTL
rs111863048	chr20:30327501:C:T	-	0.239415254161548	0.0247863571495201	BLCA	Female-baised eQTL
rs6119001	chr20:30304880:G:T	-	0.177745539823643	0.0250569605805162	BLCA	Female-baised eQTL
rs375288890	chr20:30346678:G:T	-	0.234905088989976	0.0320789137655001	BLCA	Female-baised eQTL
rs60897953	chr20:30329969:C:T	-	0.192758156774064	0.0383784442269983	BLCA	Female-baised eQTL
rs6119126	chr20:30407048:G:C	-	0.189334381695165	0.0387397092856163	BLCA	Female-baised eQTL
rs1292938	chr20:38569058:A:C	-	0.111731788289453	0.0388524083889067	BLCA	Female-baised eQTL
rs11907419	chr20:30340604:G:A	-	0.166481965970951	0.040555568139562	BLCA	Female-baised eQTL
rs6119082	chr20:30371759:C:T	-	0.166481965970951	0.040555568139562	BLCA	Female-baised eQTL
rs6119036	chr20:30331703:T:C	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119037	chr20:30332269:C:G	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119038	chr20:30333450:C:T	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs112624490	chr20:30343505:C:T	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119053	chr20:30343944:C:T	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs11908385	chr20:30350104:A:G	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6118896	chr20:30350757:A:G	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119063	chr20:30353898:T:G	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6118901	chr20:30357155:A:T	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119070	chr20:30357912:G:A	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119071	chr20:30359747:T:A	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs1955266	chr20:30359805:G:A	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6118903	chr20:30363975:C:T	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs4337546	chr20:30377177:G:A	-	0.165156914462157	0.0443623227437665	BLCA	Female-baised eQTL
rs6119007	chr20:30307482:T:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6118876	chr20:30307727:T:C	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6119008	chr20:30307800:T:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6119013	chr20:30308652:T:C	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6118877	chr20:30308653:G:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs7264111	chr20:30309083:T:C	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs7274062	chr20:30309135:C:T	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6118879	chr20:30309505:G:T	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6119014	chr20:30309535:G:C	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs6119018	chr20:30313448:A:G	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs12481195	chr20:30316128:G:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs146471460	chr20:30316230:G:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs376429732	chr20:30317982:C:A	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL
rs181166610	chr20:30317983:A:G	-	0.164318520967344	0.047450245213656	BLCA	Female-baised eQTL

Female-specific eQTL regulation.

SNP ID	SNP Info	Position to Gene	Effect Score	FDR	Cancer Type	Biased Type
rs3092217	chr20:41751429:C:T	-	-0.0603806594737531	0.0472139969459249	LIHC	Male-baised eQTL
rs6031593	chr20:44422573:T:C	-	0.0517271779298816	0.0289071650932034	BLCA	Male-baised eQTL
rs149437376	chr20:39287135:A:G	-	-0.0900442847128299	0.0386545673906809	COAD	Male-baised eQTL
rs6101477	chr20:39352861:C:T	-	-0.0646390781293208	0.0464987335904305	COAD	Male-baised eQTL

Opposite sex-biased eQTL regulation.

SNP ID

SNP Info

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Sex-biased Gene in Cancer

Cancer Type

Top

Sex-biased eQTM regulation of gene

Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table).

eQTM	Description
	Gene ID: ENSG00000149639
	CpG Site: cg01599925
	Position to Gene: gene,exon,UTR
	Male Effect: -0.444024883625523
	Female Effect: -
	Gene ID: ENSG00000149639
	CpG Site: cg09589443
	Position to Gene: gene
	Male Effect: -0.444024883625523
	Female Effect: -
	Gene ID: ENSG00000149639
	CpG Site: cg01844321
	Position to Gene: gene,promoter
	Male Effect: -
	Female Effect: -0.10790603940176

Male-specific eQTM regulation.

CpG Site	CpG Postion	Position to Gene	Effect Score	FDR	Cor.r	Cor.Pvalue	Cancer Type
cg01599925	chr20:36859621	gene,exon,UTR	-0.444024883625523	1.53651684401501e-08	-0.5416974975247684	6.849095054794223e-12	THCA
cg09589443	chr20:36860818	gene	-0.444024883625523	1.53651684401501e-08	-0.5416974975247684	6.849095054794223e-12	THCA

Female-specific eQTM regulation.

CpG Site	CpG Postion	Position to Gene	Effect Score	FDR	Cor.r	Cor.Pvalue	Cancer Type
cg01844321	chr20:36862412	gene,promoter	-0.10790603940176	3.24526339288204e-05	-0.33164939018665196	5.8184545868879666e-08	LUAD

Opposite sex-biased eQTM regulation.

CpG Site

CpG Postion

CpG Island

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Male Cor

Male P-value

Female Cor

Female P-value

Sex-biased Coding Gene

Cancer Type

Top

Sex-biased sQTL regulation of gene

Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTL

Description

Male-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Female-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Opposite sex-biased sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Male Effect

Male FDR

Female Effect

Female FDR

Cancer Type

Top

Sex-biased sQTM regulation of gene

Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTM

Description

Male-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Female-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Opposite sex-biased sQTM regulation.

EX ID

EX Info

Skipped Exon

CPG Site

CPG Position

CPG Island

Position to EX Events

Male Effect

Male FDR

Female Effect

Female FDR

Male Correlation

Male P-value

Female Correlation

Female P-value

ORF_anno

Cancer Type

Top

Related disease information of SOGA1

Diseases associated with this gene (DisGeNET).

Gene ID

Gene Symbol

Disease ID

Disease Name

Number of PMID

Source

	Gene summary
	Gene structure and Gene expression level
	Sex-biased somatic mutation
	DNA methylation with beta values in gene
	Exon skipping events with PSI in TCGA
	RNA A-to-I editing events in TCGA
	Sex-biased TF-Gene network of gene
	Sex-biased RBP-ES network of gene
	Sex-biased CeRNA regulation of gene
	Sex-biased eQTL regulation of gene
	Sex-biased eQTM regulation of gene
	Sex-biased sQTL regulation of gene
	Sex-biased sQTM regulation of gene
	Related disease information of gene